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Abstract
Background: Hypertension, itself a cardiovascular condition, is a significant risk factor for other cardiovascular
diseases. Hypertension is recognized as a major public health challenge in Ghana. Beginning in 2014, a collaborative
team launched the community-based hypertension improvement program (ComHIP) in one health district in
Ghana. The ComHIP project, a public-private partnership, tests a community-based model that engages the private
sector and utilizes information and communication technology (ICT) to control hypertension. This paper, focuses on
the various challenges associated with managing hypertension in Ghana, as reported by ComHIP stakeholders.
Methods: A total of 55 informants – comprising patients, health care professionals, licensed chemical sellers (LCS),
national and sub-national policymakers – were purposively selected for interview and focus group discussions
(FGDs). Interviews were audio-recorded and transcribed verbatim. Where applicable, transcriptions were translated
directly from local language to English. The data were then analysed using two-step thematic analysis. The protocol
was approved by the two ethics review committees based in Ghana and the third, based in the United Kingdom.
All participants were interviewed after giving informed consent.
Results: Our data have implications for the on-going implementation of ComHIP, especially the importance of
policy maker buy-in, and the benefits, as well as drawbacks, of the program to different stakeholders. While our
data show that the ComHIP initiative is acceptable to patients and healthcare providers – increasing providers’
knowledge on hypertension and patients’ awareness of same- there were implementation challenges identified by
both patients and providers. Policy level challenges relate to task-sharing bottlenecks, which precluded nurses from
prescribing or dispensing antihypertensives, and LCS from stocking same. Medication adherence and the
phenomenon of medical pluralism in Ghana were identified challenges. The perspectives from the national level
stakeholders enable elucidation of whole of health system challenges to ComHIP and similarly designed
programmes.
Conclusions: This paper sheds important light on the patient/individual, and system level challenges to
hypertension and related non-communicable disease prevention and treatment in Ghana. The data show that
although the ComHIP initiative is acceptable to patients and healthcare providers, policy level task-sharing
bottlenecks preclude optimal implementation of ComHIP.
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Background
Raised blood pressure, has since 1972 been acknowl-
edged as a risk factor for cardiovascular disease and
mortality [1]. It is one of the top ten causes of death glo-
bally; estimated in 2010 to have contributed to 9.4 mil-
lion deaths [2]. Data from the 2005, 2010, and 2015
Global Burden of Disease (GBD) studies call on stake-
holders to address the heavy burden that raised blood
pressure exacts on global public health [3–5]. The 2015
GBD analysis identified raised blood pressure (commonly
defined as systolic blood pressure over 115), among four
others (smoking, high blood sugar, high body mass
index, and childhood undernutrition), to be the world’s
leading risk factors for premature death [5]. If not man-
aged, hypertension (commonly defined as a systolic
blood pressure ≥ 140 or diastolic blood pressure ≥ 90),
can cause several health problems including heart attack,
stroke, heart or kidney failure, and blindness [6]. Raised
blood pressure affects approximately 22% of adults over
the age of 18 years, with low and middle-income countries
(LMIC) bearing the largest burden where it is estimated
that by 2020, 80% of the cardiovascular disease burden
will reside [6]. The World Health Organization (WHO)
further notes that by 2020, three out of four of all deaths
in Africa may be attributable to raised blood pressure [6].
Despite the high global burden of hypertension, aware-
ness and treatment are low, with only 34% of Africans
aware of their hypertension, 31.3% receiving treatment
and only 6.5% with their hypertension considered to be
under control [7]. In Ghana, between one-quarter to
one-third of adults have hypertension, though only a mi-
nority of those with the disease are aware of their status:
approximately 37% of women and 20% of men according
to recent local surveys and reviews [8–13]. These studies
show that among those with hypertension in Ghana,
even a smaller proportion, between 1.7 and 12.7%, have
their hypertension controlled. Unfortunately, having
traditionally focused its resources on addressing commu-
nicable diseases and maternal and child health, there is
inertia in refocusing and reprioritization of the Ghana
healthcare system to emerging challenges.
The current paper presents perspectives of Ghanaian
stakeholders involved in a multi-facetted community-
based hypertension improvement initiative – herein re-
ferred to as the community-based hypertension im-
provement program (ComHIP). The paper reports a
nuanced understanding of the patient-level and context-
ual challenges associated with managing hypertension
and related NCDs in a Ghanaian district.
Ghana’s health service delivery system challenges and
priorities
To provide a nuanced understanding of the various chal-
lenges associated with managing NCDs in Ghana, an
introduction to the challenges and priorities of Ghana’s
health service delivery system is necessary. Since the
founding of the current national health system – post in-
dependence, key actors in the health policy making
process have tended to be the same actors that play key
roles in health agenda setting, design, adoption, imple-
mentation and sustainability in Ghana. The main gov-
ernmental actors have been the Ministry of Health
(MOH) and key agencies such as the Ghana Health Ser-
vice (GHS). Lately, however, other actors such as multi-
lateral agencies, bilateral/development partners, and
local faith-based health service delivery actors, such as
the Christian Health Association of Ghana (CHAG) have
emerged. The local civil society, and a few lay advocates,
although wielding minimal influence, advocate for finan-
cial resources to be made available for priority interven-
tions. Despite some successes in terms of such advocacy,
a number of challenges continue to confront Ghanaian
health policy formulation and implementation – espe-
cially prioritization and resource allocation. Although
the sector considers NCDs an emerging public health
problem, longstanding health challenges such as infec-
tious diseases, maternal, neonatal and new-born deaths,
malaria, and sanitation continue to receive a significant
proportion of health system allocation.
Aside from the prioritization and system-level chal-
lenges, there are acknowledged inequities in health ser-
vice delivery or receipt of same. To address some of
these inequities, the National Health Insurance Scheme
(NHIS), Ghana’s first social protection efforts that ad-
dressed NCDs, was born [14]. The NHIS aims to in-
crease access to health care and improve the quality of
basic health care services for all persons living in Ghana,
but especially for the poor and the vulnerable. Prior to
the scheme, the majority of health care costs were paid
out-of-pocket by individuals and families (a system that
was referred to as ‘cash-and-carry’). Currently both pub-
lic and private health care providers throughout Ghana
provide healthcare through the scheme [15]. The
scheme’s benefit package covers about 95% of diseases
in Ghana including hypertension.
The ComHIP project
With funding from the Novartis Foundation, Basel,
Switzerland, FHI360 in 2014 collaborated with the
Ghana Health Service (GHS) to launch the community-
based hypertension improvement program (ComHIP) in
one health district in Ghana (the Lower Manya Krobo
Municipality, Eastern Region). ComHIP, which delivers a
series of implementations, is being evaluated for impact
and cost-effectiveness. The intervention comprises a pack-
age of evidence-based interventions that were adopted,
adapted, and implemented in Ghana. Key components of
the intervention include community-based blood pressure
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screening, management of hypertensive clients by
community-based nurses (community cardiovascular dis-
ease nurses), blood pressure monitoring and supportive
messaging to clients and service providers using informa-
tion and communication technology (ICT) tools. Envis-
aged to be implemented by community pharmacists, and
Licensed Chemical Sellers (LCS), dispensing of anti-
hypertension drugs could not be implemented. The over-
all community-based intervention and evaluation strat-
egies are detailed in [12]. Currently referred to as over-
the-counter medicine practitioners, LCS in Ghana are per-
mitted to supply retail restricted drugs other than Class A
or B drugs. Community pharmacists, per local guidelines
are higher cadre private service providers. They supply
medicines in accordance with a prescription or, when le-
gally permitted, sell them without a prescription. Unlike
the LCS, the main activities of community pharmacists in-
clude processing of prescriptions, care of patients, moni-
toring of drug utilization, and health promotion.
Prior to ComHIP, the FHI360, the GHS, and others
developed and implemented a general education and
CVD screening programme in the district in which
ComHIP was implemented. As part of this earlier
programme, counselling, health education and lifestyle
modification interventions were provided alongside
screening for hypertension. The study revealed hyperten-
sion as a major problem in the setting – reporting a
prevalence of 32% among females and a little over 34%
among males [16]. Baseline data from the ComHIP pro-
ject show similar prevalence of hypertension- 32.4%. The
data further show that although 46.2% of those diag-
nosed to be hypertensive were aware of their hyperten-
sion status, only 9% were treated and 1.3% of patients
had their blood pressure under control. Furthermore, we
found in-depth knowledge of hypertension risk factors
to be low despite the high level of knowledge about the
burden of the condition. Overall, close to 50% of the
adult population were overweight or obese [12]. Thus,
challenges revealed by these surveys is the high mis-
match between hypertension knowledge and hyperten-
sion diagnosis, treatment or control. The existence of
low blood pressure control rates in the intervention dis-
trict despite previous generalized education programs
[16] suggests that such programs have little impact on
hypertension control.
Following the baseline study, we qualitatively assessed
ComHIP implementation barriers, enablers, and factors
influencing adherence (this is reported elsewhere; see
Adler et al., forthcoming). This paper focuses on health
system factors, service provision factors and service user
factors that impact hypertension prevention, manage-
ment, and control in Ghana. Publicizing the findings not
only shares implementation experiences, it also offers
stakeholders the opportunity to appreciate identified
challenges and propose solutions as they explore scale
up options. Beyond ComHIP, the study findings may
provide guidance to similarly-designed interventions.
Methods
Study design
The ComHIP evaluation is conducted in two peri-urban
districts in Ghana – the Lower Manya Krobo Municipal-
ity (intervention site), and the Akuapim South District
(comparison site). The comparison district, which pro-
vides the current GHS hypertension services, is distant
enough to minimize contamination. The evaluation em-
ploys before-after population-based surveys (in interven-
tion and control districts), and a prospective cohort
study in the intervention district (for details, see Lamp-
tey et al. [12]. Conducted among hypertensive patients
enrolled in the cohort are a series of patient centered-
ness surveys and qualitative investigations among vari-
ous ComHIP stakeholders.
The design of the qualitative study is informed by the
WHO Health Systems Assessment Framework [17] and
the WHO’s identification of five interacting dimensions
that affect adherence [18]. This framework depicts
health systems using six interrelated units or building
blocks. These are service delivery, health workforce, in-
formation, medical products, vaccines and technologies,
financing, and leadership/governance. Having been pre-
viously used to analyse the relationships between health
system levels for cardiovascular or hypertension condi-
tions [19], this framework facilitated the identification of
systems-level barriers to hypertension care in Ghana.
The five interacting dimensions of adherence [18] en-
compass social and economic factors, health systems fac-
tors, condition-related factors (in the current case,
hypertension or NCD), treatment-related factors, and
patient-related factors. As hypertension care and associ-
ated challenges are determined by the interplay of sev-
eral factors, the study tools were fashioned with these
dimensions in mind. The two frameworks facilitated the
exploration and appreciation of the multiplicity of fac-
tors impacting hypertension care. Thus system-level fac-
tors such as governance and prioritization of NCDs
within the Ghana health service delivery system; human
resource constraints, policy-informed task-sharing chal-
lenges; and patient-level challenges such as life-long
management of hypertension, adherence to medications
and medication side effects; and socio-political questions
of medical pluralism were investigated.
Study respondents
A total of 55 informants were purposively selected to
represent the characteristics of each category of study
participants (see Table 1 below). We selected registered
patients and ensured a mix of gender, age, district, and
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socio-economic status. Health care providers were se-
lected to ensure representativeness of hospitals, and LCS
to ensure their representativeness of the studied com-
munities. Policymakers from the Ministry of Health/
Ghana Health Service were selected based on the rele-
vance of their position within NCD control. They in-
cluded the National Programme Managers, Regional
Directors of Health Services, Policy, Planning, Monitor-
ing and Evaluation Officers.
Study tools development, field staff recruitment, training,
and data collection
As described above, the design and the tools of this qualita-
tive study benefit from the WHO Health Systems Assess-
ment Framework [17], and the WHO resource relating to
five interacting dimensions of medication adherence [18].
The framework and associated questions captured in our
tool facilitated our identification of health systems-level
barriers to hypertension care in Ghana. We developed five
separate, yet related tools – one tool for healthcare profes-
sionals (semi-structured interview guide); this tool covered
topics such as: a) experience and tasks; b) how treatment
and care is provided and coordinated; c) how treatment
has changed with the programme; d) their relationships
with patients; and e) areas for improvement at the health
systems level). The second tool was used to engage health
policymakers (a semi-structured interview guide). The in-
terviews with policy-makers were tailored to their expert-
ise and position. The interviews focused on understanding
NCD programmes, the key barriers in the implementation
of hypertension programmes, key health systems-level fa-
cilitators, who the key actors are, aspects that need im-
provement, and the commitment to scaling up the
ComHIP programme. For hypertensive patients, we devel-
oped both a semi-structured interview guide, and a focus
group discussion (FGD) guide. The specific interview and
focus group discussion topics for hypertensive patients en-
rolled in the ComHIP intervention include: a) how treat-
ment and prevention of hypertension is provided; b)
health care experience and recommendations; c) know-
ledge of hypertension and its diagnosis; d) health system
barriers and facilitators to accessing services and receiving
care for hypertension; e) factors influencing adherence.
For licensed chemical sellers (focus group discussion
guide), the topics included a) their experience and percep-
tions of the programme b) scalability. These tools are con-
solidated and appended to the manuscript as a
supplementary material (see Additional file 1).
Using the above tools, three experienced multilingual
qualitative field researchers –fluent in English, Krobo or
Twi carried out face-to-face semi-structured interviews
and FGDs. Two researchers (co-authors AJA and AK)
conducted an intensive one-week training session for the
qualitative field staff to ensure that interviewers under-
stood the objectives of the study and the questions. They
were trained to respond to any sensitive situations or signs
of distress with appropriate wording, supportive state-
ments and avoidance of excessive probing. The training
included extensive role plays, and trialing of the tools. The
issues and experiences from the trial process were incor-
porated into the tool prior to actual data collection.
Based on participant preference, interviews and FGDs
were conducted in English, Krobo or Twi and audio re-
corded. The categories of the study participants are sum-
marized in Table 1. We interviewed 15 hypertensive
patients enrolled in the intervention, 10 health care pro-
fessionals (seven CVD nurses, one pharmacist, one phys-
ician assistant, and one physician), seven health
policymakers. We conducted two FGDs with a total of
16 patients (one group of men, and one of women). We
conducted a third FGD with seven LCS.
Data analysis and quality assurance
The interviews were audio recorded and transcribed ver-
batim. The transcriptions were translated directly from
the local languages to English by experts in English and
Krobo or Twi, and wherever possible by the individual
who conducted the interview. Our quality assurance mea-
sures included recruitment of experienced multilingual
qualitative researchers, and conducting a one-week training
on the study methods, tools, and ethics. During the tran-
scription process, co-author AK randomly sampled 10% of
the translated transcripts and compared them with the ori-
ginal recordings. The data were then analysed using the-
matic analysis techniques employing two steps. We started
with a-priori chosen themes based on the ComHIP interven-
tion themes. We coded transcripts based on both the a-
priori analysis and emergent and divergent themes that came
from the analysis. We then looked to find overarching con-
cepts in which the themes were interconnected. Co-authors
AJA, AK, AKL, and field assistants met to discuss major
themes and issues that were not clear in the transcriptions.
Ethics
Our study protocol received ethics approval from the In-
stitutional Review Boards (IRBs) of the London School
Table 1 Categories of informants
Informants Semi-structured
interviews
Focus Group
Discussion (FGD)
Total
Patients 15 16 31
Health care
professionals
10 – 10
Licensed chemical
sellers
– 7 7
Policymakers 7 – 7
Total 32 23 55
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of Hygiene and Tropical Medicine (LSHTM) - Observa-
tional / Interventions Research Ethics Committee (Ref:
10152), the Ghana Health Service – Ghana Health Ser-
vice Ethics Review Committee (Ref: GHS-ERC 04/01/15)
and the Noguchi Memorial Institute for Medical Re-
search, University of Ghana (Ethics clearance #
IRB00001276). Participating in the study was preceded
by a written informed consent processes, which commu-
nicated to prospective participants that their participa-
tion in the study was voluntary. It also outlined
measures that the researchers would put in place to en-
sure privacy, anonymity and confidentiality. Briefly, the
measures instituted by the study team to ensure that
participants’ confidentiality is maintained included the
following. Personal identifiers were not included in study
reports and manuscripts. All study records were secured
to the extent provided by local and international regula-
tions. Data collection forms were identified by codes; all
records containing names or other personal identifiers,
such as informed consent forms were stored separately.
The required anonymization procedures were imple-
mented prior to depositing transcripts in Harvard Data-
verse (an open access repository). Regarding privacy,
interviews were conducted in private and comfortable
spaces that the participant deemed acceptable. All par-
ticipants consented to the publication of their data.
Results
Presented below are both health system level challenges
and patient level associated with managing hypertension
in a district benefiting from the ComHIP intervention.
The health system level challenges span governance and
prioritization of NCDs within the Ghana Health Service
delivery system; human resource and task-sharing chal-
lenges; and challenges of medical pluralism of illness
and treatment. Hypertension-specific challenges relate to
integrating hypertension prevention and screening within
the health system, and provision of hypertension preven-
tion and treatment at primary care facilities. Also pre-
sented are several patient-level challenges including
inadequate understandings of medications, medication
adherence, and side effects.
Governance and prioritization of NCDs within the Ghana
health service delivery system
Key stakeholders of the GHS (national, regional, and dis-
trict level policymakers, health professionals and clients)
shared their perspectives on the systemic health system-
wide challenges as a whole, and in particular, manage-
ment of NCDs within the Ghana health delivery system.
In particular, the perspectives from the national level
policymakers enabled elucidation of prevailing system-
wide challenges (beyond ComHIP intervention district)
such as a mismatch between prioritization of NCDs and
current level of funding for NCDs interventions. Policy-
makers consider NCDs as an emerging public health
problem. Longstanding health challenges such as infec-
tious diseases, maternal, neonatal and new-born deaths,
malaria, and sanitation continue to be health sector pri-
orities. The current level recognition of NCDs is
reflected in the government’s financing strategies. A sig-
nificant proportion of health system allocation goes to
maternal, child health and infectious disease pro-
grammes. However, the pendulum, in a foreseeable
future, is likely to swing toward NCDs, as their bur-
den, particularly hypertension-related morbidity and
mortality are increasing. A GHS official at the district
level explained the situation as follows:
Ghana being a developing country, our focus is more
on how to combat communicable diseases. Now the
number of NCDs is also increasing and the large
number of clients that come to the facilities is a matter
of concern. Previously, we see older people having the
disease. But now we find younger people coming. Also,
many people come with stroke or die suddenly. The
increasing burden of hypertension in our communities
and facilities is gradually changing health sector
prioritization. (District-level GHS official).
Beginning in 2012, the Ministry of Health developed a
national policy for the Prevention and Control of NCDs
in Ghana [20]. An accompanying strategy, the strategy
for the Management, Prevention and Control of Chronic
Non-Communicable Diseases in Ghana 2012–2016 [21]
was also developed. The NCD strategy outlines, amongst
others, health promotion, community engagement and
outreach and covers advocacy, creating awareness, screen-
ing for early detection, diagnosis and management and
research.
Although Ghana’s national policy and accompanying
strategy for NCDs have been in existence since 2012, in-
adequate logistics and financial resources limit their im-
plementation. Policymakers revealed that unlike
infectious diseases, or maternal and child health issues,
there are no defined sources of funds from the Ghanaian
government for awareness creation, screening and pre-
vention of hypertension. Policymakers reported that the
major challenge to the control of hypertension in Ghana
is the lack of awareness, or knowledge (on the part of
the populace) as well as the GHS’ lack of resources.
Most of the GHS interviewees noted that GHS lacked
funds for awareness creation and community-based edu-
cation. Health promotion is generally carried out through
media campaigns, primarily radio, where knowledgeable
persons discuss risk factors for specific NCDs, clinical
presentation, treatment, and possible complications. How-
ever, these programmes do not provide the opportunity
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for people to call in and ask questions and clarify issues.
Many policymakers noted that at public health facilities,
only opportunistic screening is done due to a lack of
screening facilities’ equipment and staff. This is seen
through the strain that the current ComHIP programme
has put on the hospitals in the Lower Manya Krobo (the
ComHIP intervention district). There is a concern that in-
creased screening may increase demand to greater than
the health services’ capacity to treat the screened
individuals.
Human resource constraints and task-sharing challenges
Related to inadequate logistics and financial resources is
the problem of human resource. Ghana’s precarious
health workforce situation, particularly its inadequate
number of doctors, is detrimental to effective health de-
livery including NCD management. Three policymakers
independently noted that the NCD unit, just as other
sectors of GHS, has serious human resource challenges.
Throughout the country, particularly in remote settings,
limited number of trained personnel exacerbate already
existing service delivery inequities. A substantial chal-
lenge faced by the ComHIP project was the shortage of
trained staff (particularly doctors) with hypertension
medication prescribing authority and expertise for
hypertension treatment and management. A CVD
nurse’s complaints and the views of a service user par-
ticipating in a focus group illustrate this challenge.
Unlike the situation with other drugs such as anti-
malaria drugs and some antibiotics in pregnancy we
prescribe, only doctors give prescription in the case of
NCDs. This leads to long waiting and difficulties acces-
sing needed medications. (Community based CVD
nurse)
This complaint (below) about wait times at hospital
during visits for ordinary monitoring of blood pressure
is emblematic of others recorded during the focus
groups. Discussants of the focus groups offer task-
sharing suggestions to address this problem.
For me, my major challenge is that sometimes you are
just in need of your BP drugs but you will get to the
hospital very early and leave there very late, so to me
if they can arrange and group BP patients at one
side so that you join that queue and go for your
medicine immediately. Perhaps the nurses who
counsel us can be permitted to have the medicines so
that once in a month when we go to see them they can
give us the medicine. That will be simple. Imagine going
to join the long queue just for medicine; I prefer to go to
the drug store to buy them myself. (A female FGD
participant)
The human resource challenge impacts nationwide in-
tegration of hypertension prevention and screening
within the health system. Aside from a shortage of ex-
perts, there are challenges of their distribution across
the country with varied regional and district disparities.
A common theme that emerged from conversations was
that facilities in deprived areas are severely understaffed.
Many doctors are not willing to accept postings to rural
areas where more health care professionals are needed.
While the number of medical schools is increasing as
part of the national strategy to train more staff locally,
there are huge inequities of trained personnel, particu-
larly doctors with expertise. Many of them move to
more desirable areas or leave the GHS.
Deprived, hard-to-reach areas (sometimes referred to,
in Ghanaian parlance, as “overseas”) are severely un-
derstaffed. When serious cases show up at the district
hospitals, they are referred to regional hospitals. Cur-
rently, these clinics are much less common, so if one
does not live near a district or regional hospital, one is
unlikely to get specialist care for NCDs including
hypertension and other chronic conditions. That there
is unequal geographical distribution of healthcare pro-
fessionals is no news to us. (National-level policy
maker)
This inequitable distribution of high cadre health
workforce precludes integration of hypertension preven-
tion and care into lower level service delivery points
where providers do not have antihypertensive prescrib-
ing authority or lack hypertension management experi-
ence. Alluded to earlier, unlike other conditions, in
Ghana management of hypertension is hospital-based
with doctors as prescribers, and service provided by spe-
cialised clinics run once or twice a week at district and
regional hospitals. Lower cadre service providers such as
nurses do not have prescribing or dispensing power.
Hypertension treatment and access-related challenges
Aside from task-sharing access-related challenges de-
scribed above, financial access is an important challenge.
Of note, hypertension is covered by the NHIS, therefore,
all patients theoretically have access to hypertension care
in Ghana. The precondition, however, is to enrol in the
NHIS scheme and pay the subsidised annual premium
(GH25.00 about US$6.00). Exemptions are also provided
for various vulnerable groups. Despite this initiative,
some health professionals in public health facilities
expressed their frustration with the NHIS scheme and
the challenge of accessing hypertension medications.
While the assumption was that most patients had health
insurance cards, many informants felt that there were
still many out of pocket costs including transport. This,
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combined with the time spent by patients getting pre-
scriptions, led to substantial challenges.
Others pointed to the challenges of the NHIS as having
a negative impact on hypertension treatment.
In particular, the delayed reimbursement of health fa-
cilities by the National Health Insurance Authority
(NHIA) seriously affects health facilities’ stock of medi-
cines and other supplies.
Unfortunately, health insurance has not paid our
claims for close to a year now. We are in April and the
last claim that was paid to all our health facilities
was April last year, 2016. So that is 11 months that
they haven’t paid us, and you know the drugs you
procure from regional medical stores or you procure
from the open market and you have to pay for the
drugs and the patient knows. If he or she is on health
insurance then antihypertensive drugs, the majority of
them, are on the inclusion list so they are provided to
him or her free of charge. Yes, when it comes to the
facility level because they don’t have money to pay
supplies so then they have to put in maybe a payment
or co-payment. So maybe now the health insurance is
not paying us so you have to pay half and the facility
is also paying half just for the facility to survive, or if
they don’t have drugs in some of the facilities then they
will just write prescription for you to go and buy at the
pharmacy shop or chemical shop. And you know some
of them because it is cash when they go they may not
buy it and take their drugs. (District level nurse)
A related access challenge identified by many infor-
mants was the unavailability of essential drugs at lower
level service delivery points. Community health nurses
reported that some patients only took one round of
medications and did not refill their prescriptions due to
the cost of transport to NHIS accredited facilities. Also,
many community pharmacists do not stock antihyper-
tensive drugs, making it difficult for patients who are
able to purchase them to travel longer distances to ob-
tain them. A service provider expressed her frustration
about getting medication for their patients in the follow-
ing comments:
At the community level, you may have to travel to get
your medicines. What’s the point if I diagnose and I
can’t give medicine? If I go to the nearest health centre
and I diagnose someone to have hypertension then I’m
working at the health centre, I don’t store
antihypertensive drugs so I give you a prescription and
you have to go to the regional hospital, that is a
problem. Why doesn’t the client just go to the regional
hospital for diagnosis and treatment? (Senior member
of the GHS)
Patient-level challenges: life-long management of
hypertension, adherence to medications and medication
side effects
One of the biggest challenges to effective hypertension
control mentioned by most informants was adherence to
medications. Our results show that with the exception of
a few, patients are aware of the necessity of the continu-
ous taking of medications but do not do so. Reasons
given for non-adherence included the inaccessibility and
unavailability of drugs, non-acceptance of life-long man-
agement of hypertension, side effects associated with
the drugs and perceptions of traditional medicines as
curative.
All participants of the two focus groups knew that they
should talk to their health care providers if they had any
side effects or problems with any hypertension medica-
tions. No patient reported receiving incorrect doses of
drugs when prompted, and no nurse knew first hand of a
patient receiving the wrong dose. Both patients and nurses
had concerns about side effects, which included too fre-
quent urination and erectile dysfunction for men. Nurses
cited side effects as the primary cause of non-adherence,
and a few hypertensive focus group participants stated
that they switched medications because of side effects.
The influence of side effects on medication adherence
seemed greater in men, compared to women. One nurse
noted. “Men are more reluctant to take antihypertensive
drugs because of the sexual side effects.” . Another nurse
elaborated with a clarification:
… the main reason why males are likely to stop taking
medications is side effects, while females stop if they
feel their BP has gone down. They asked, ‘why should
they continue taking the drugs if they are okay?’
The above was corroborated by views of some hyper-
tensive participants. One male participant expressed
their worry about the medicine's effect on his sex life.
I had erectile dysfunction and had told the CVD
nurse, but she laughed and did not change my
medicines. So, I chose to stay off the drugs for a while.
A nurse reported that patients would wait too long to
report problems with their medications:
When they start experiencing side effects, instead of
reporting immediately, they stop taking their
medications and wait until their next visit. Some
will not even come to you at all.
We also explored the challenges associated with the
life-long management of hypertension. For instance, ad-
herence was hampered as many patients did not realize
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the medications were meant to be continued even after
their blood pressure was lowered. One participant gave
an example of stopping taking the drugs once the symp-
toms disappear.
I have seen that you can’t stop the medication. I’m
saying this because during Christmas I stopped taking
my medication so that I could enjoy the season but
after Christmas I realized that my heart started
beating abnormally again. When I went to check it
was around 200. The doctor told me that I have
stopped taking my medication. I tried to lie but he
insisted that I had stopped. He gave me some
medications that I took for three days. I went back and
the BP reduced to 130 and he told me it’s because I
have taken the medication this time.
A pharmacist attributed the life-long hypertension
treatment challenge to polypharmacy.
The quantity of drugs given to patients to take
discourages them from adhering for a long time. The
sheer number of drugs discouraged them, although it
was noted that if you gave patients too few
medications they would also complain.
Reconciling two health systems and cultures: traditional
medicine vs Western medicine
The desire for curative drugs rather than management is
a major barrier to adherence to antihypertensive medica-
tions. There are many traditional or herbal medications
in Ghana that are perceived to cure hypertension. While
antihypertensive drugs are taken for life to manage the
condition, traditional/herbal medicines purport to be
curative. This perception often discourages people from
accessing allopathic care and if they do, continuation of
the treatment for life is a challenge. According to nurses,
some of their clients reported taking traditional medi-
cines. Some of the patients also told us they took trad-
itional medicines but did not tell the CVD nurse and
admonished us not tell them. A participant said prior to
ComHIP he nearly had a stroke and started taking
herbal medications that were made by his brother. How-
ever, when he combined the herbal and allopathic medi-
cations, he experienced some negative effects, so he
stopped taking the local one. Another participant stated
that he only sought hospital care out of his concern of
not having sufficient traditional medicines.
The illustrations below show the popularity of traditional
medicines, which are sometimes taken concomitantly with
allopathic antihypertensives or may be used as a substitute
for the allopathic medications:
R: I take the medicine but stopped because I’m taking
the local one. Now I’m yet to start the foreign
medication. I take it because the lady selling it told me
it’s good for hypertension.
I: So, you combine the two?
R: No, the seller told me to stop the hospital one for
some time so that I won’t mix the two drugs till I
finish the local one. Recently when I came here, and
they checked my BP they asked me if I’m taking some
other form of medicine in addition to the foreign ones
and I told them yes. (Female participant)
She used to be on the hypertensive drug and then she
stopped before I met her. Some of them told me they
stick to some herbal medicine because when they
checked and realised the BP is okay, they stopped the
hospital one. So, for me to diagnose again, it means
that the herbal medicine is not working so we have to
go and follow the orthodox way again. (Community
CVD nurse)
Discussion
We explored Ghanaian stakeholders’ perceptions of a
multi-facetted community-based hypertension improve-
ment initiative with task-sharing components. This paper
presents and discusses several patient-level and contextual
challenges associated with the implementation of the ini-
tiative – focusing on the management of hypertension
and related NCDs. The findings have implications
on the implementation of ComHIP and on the design
of related task-sharing strategies in Ghana. Publicizing
the findings not only shares implementation experiences,
it also provides stakeholders an opportunity to appreciate
and address identified challenges as they explore possibil-
ities of scaling up this initiative.
Although, our data show that the ComHIP initiative is
acceptable to patients and healthcare providers (Adler
et al, forthcoming) – increasing providers’ knowledge on
hypertension and patients’ awareness of same, the import-
ant challenges identified by both patients and providers
are worth discussing. The key policy level challenges relate
to task-sharing bottlenecks. Existing policy precluded
lower-cadre services providers such as nurses from pre-
scribing or dispensing antihypertensives, and LCS from
stocking them. Medication adherence, side effects, and the
phenomenon of medical pluralism in Ghana are other
challenges. Although focused on the ComHIP interven-
tion currently being implemented in one health district,
views from national level stakeholders are reflected in this
paper. Their perspectives enable elucidation of contextual
and system-wide challenges such as a mismatch between
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prioritization of NCDs and funding NCD interventions by
the Ghana health delivery system.
Ghana’s health service delivery system challenges and
priorities
Like many LMICs, Ghana’s fragile health system is deal-
ing with multiple burdens of disease as well as non-
disease health system challenges. Thus, the emerging
challenge of NCDs (whose impact on the health system
is real) adds to existing layers of challenges that the
country’s health system has to contend with. Ama de-
Graft Aikins [22] has recently discussed the impact of
CVD on primary healthcare (PHC) services in urban
poor communities in Ghana – laying bare the significant
unmet need for CVD care in these communities. Na-
tional level stakeholders in the current study acknowl-
edged the growing challenge of NCDs. Like other
countries in the sub-region, Ghana is experiencing rapid
urbanisation, accompanied by increasing levels of obesity
and related NCDs [13, 23, 24]. Data from the Global
Burden of Disease studies rank raised blood pressure/
hypertension, high fasting plasma glucose, dietary risks,
and high body mass index among the top 10 risk factors
that drive the most death and disability combined. Thus,
NCDs and their associated risk factors account for > 40%
of total morbidity and adult mortality in Ghana. In recog-
nition of the increasing burden of NCDs, Ghana has re-
cently politically recognised NCDs as a pressing health
concern, publishing national NCD prevention policies and
strategies, which identify interventions to address them
[20, 21]. Closely related to the disease burden is the chal-
lenge of funding. Although there is a growing national rec-
ognition of NCDs, particularly hypertension, there is
currently no commensurate funding response. Policy-
makers lament that the Ghana national NCD policy and its
accompanying strategy have been in place since 2012, but
their implementation has been suboptimal due to lack of
requisite resources and funding.
To address this funding challenge, Ghana turns to do-
nors or development partners who fund a significant
fraction of the health budget [25]. These development
partners play critical roles in policy design, implementa-
tion, and funding decision-making. The policymakers we
interviewed said that current funding priorities are ma-
ternal and new-born mortality, sanitation, malaria, and
other infectious diseases. Thus, though NCDs are na-
tionally recognized as a major public health challenge,
they are not given priority with the necessary funds to
address them. To respond to this high burden of NCDs,
and yet low resources to address them, studies recom-
mend health systems-wide strengthening, which has
positive externalities on persons with NCDs, as well as
their families, and communities [26–28]. Such an ap-
proach is in line with the current ComHIP model.
Human resource and task-sharing challenges
That the Ghana healthcare delivery system is belea-
guered with workforce challenges is not new and is not
restricted to the domain of NCDs. Ghana currently has a
one doctor to 10,450 patients ratio. This falls below the
one doctor to 1320 patients WHO recommendation. All
policy level informants reiterated the lack of required
numbers of high calibre personnel as a major challenge.
In particular, the distribution of the few qualified
personnel is concentrated in a few major cities, leaving
significant portions of the Ghanaian population to be
attended to by low cadre health personnel. However, the
problem is more serious for NCD service provision. As
one moves from the few endowed urban facilities toward
urban poor communities, healthcare services for NCDs,
particularly CVDs, are generally not accessible, equitable,
nor responsive to the needs of the vulnerable [22].
In the midst of these challenges, lie opportunities to
improve NCD prevention strategies, treatment and con-
trol in Ghana. For example, effective public-private part-
nerships (PPP), the deployment of technology, effective
exploitation of the Community-based Health Planning
Services (CHPS), and task-sharing provide important
frameworks to improve NCD care. To help address this
gap, the MOH and GHS in recent years have endea-
voured to capacitate the CHNs through the strengthen-
ing of the CHPS initiative. Currently there are about
3000 CHPS compounds in Ghana, and this is projected
to increase to 6000 by 2020. CHPS were originally
formed to provide education to mothers, children and
households. The CHNs overseeing CHPS compounds or
zones have been trained to address key areas n commu-
nity health (such as infectious disease preventative care
and maternal and child health services). Similar training
on NCDs can enhance capacity, confidence, self-efficacy
to provide basic care and support to those in need. This
approach has worked in other African countries such as
Cameroon and South Africa [29]. Recognizing the value
of the ComHIP concept, some policymakers now see
CHPS as a missed opportunity for the prevention of
hypertension and NCDs . It is an attempt to bring inte-
grated hypertension management into the community
through a system of community education and hyper-
tension screening by CHNs/CVD nurses’ referrals, and
ICT support for participants. Prior to ComHIP the only
possibility for accessing hypertension care in a typical
Ghanaian health district was in hospitals by physicians.
Given the low doctor-to-patient ratio, it is imperative
that innovative methods of reorganising care – such as
ComHIP – are utilised.
Notwithstanding this, the significant challenges en-
countered during ComHIP implementation need to be
discussed. One of the challenges encountered relates to
task-sharing (described as the process of enabling lay or
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low level healthcare personnel to fulfil a wider clinical
role and used interchangeable with "task-shifting" in this
paper), which has been acknowledged as a viable strategy
for responding to CVDs and other NCDs in LMICs [29–
32]. Ogedegbe et al. [33] in their systematic review of tri-
als on task-shifting interventions for cardiovascular risk
reduction in LMICs conclude that task-shifting strategies
are appropriate and deployable in many LMICs battling
with infectious and chronic diseases. The WHO, for ex-
ample, recommends task sharing where access to health
services is constrained by a lack of health workers [34].
Other programmes in sub-Saharan Africa have found at
least limited success when nurses were trained to man-
age hypertension (for example in DRC [35], in Nigeria
[36], in Kenya [37], and Ghana [38]. In ComHIP, whilst
results on the overall programme impact and cost effect-
iveness are still forthcoming, the data from this and earlier
qualitative analysis (Adler et al. forthcoming) suggest that
various components of ComHIP including its task-sharing
experiment was acceptable to patients and nurses involved
in the programme.
However, the Ghana health policy at present does not
permit nurses and other lower cadre health personnel to
prescribe most medications including antihypertensives.
Some of the policymakers we engaged in this study indi-
cated the desire to expand who is able to prescribe med-
ications. It would seem to us that this challenge is
not particular to Ghana. The review by Ogedegbe et al.
[33] identified barriers to task shifting in LMICs as in-
cluding policy gaps on medication prescription; weak or
non-existent referral systems to take care of complicated
cases and the inability of non-physician providers to
manage uncomplicated CVDs and their risk factors [33].
In the case of ComHIP, the inability of nurses to dis-
pense antihypertensives was a major challenge. Perhaps,
identified enablers of task-shifting such as continuous
educational training and feedback from higher level
health professionals; bridging hospital care to home care
in order to ensure continuity of patient care; and provid-
ing explicit training tools including medication/treat-
ment algorithms [33] need to be exploited. At least two
projects in Kenya and Ghana that allowed nurses to pro-
vide antihypertensives have shown promising results [37,
38]. For instance, the Ghana study pilot-tested a task-
shifting strategy for a hypertension study (TASSH), which
trained community health nurses to deliver hypertension
care. Although the nurses did not dispense antihyperten-
sives because they did not have prescribing/dispensing
power, they (nurses) had access to antihypertensives
through the coordinating physician and could dispense
them as needed based on the GHS hypertension treatment
algorithm. Thus, the study was able to circumvent the
legal limitations by having the coordinating physician sup-
ply the needed drugs to the nurses. While this project was
successful, it does not fit into the current regulations
within the GHS. In light of these findings, policies should
be amended. Indeed, our study, and that by Iwelunmor
et al. [39], explore stakeholders’ perspectives of task-sharing
as a strategy for preventing, and managing hypertension in
Ghana. Both studies show that for any task-sharing inter-
vention to be successful, a deliberate effort must be made to
not only focus on patients, or individual level characteristics,
but also to consider the role systems-level variables such as
policy, leadership, and stakeholder engagement play.
Patient-level challenges including multiple
understandings of illness and treatment and medical
pluralism
Like many others in the sub-region, patients in Ghana
have the opportunity to shop for healing from various
systems/care providers: the allopathic health services de-
livery system, indigenous/traditional care delivery systems,
as well as faith-based providers. Referred to as medical
pluralism [40] or more recently, medical diversity [41], the
use of multiple medical systems to address illness and
wellness, has been praised and criticised at the same time
[42]. The medical sociology, and anthropological literature
address the subject in-depth. Baer [43] and Goldstein [44]
discuss its evolving nature, persistence, resurgence and
concept contestations. We do not aim to interrogate the
subject further. Instead, we focus on system-level factors
that motivate concommittant use of traditional remedies
and modern medicine in Ghana [22, 45, 46].
As far as chronic disease care in Ghana is concerned,
medical pluralism's contribution has begun to emerge
[47]. Hampshire [45] interrogates medical pluralism in
the context of globalization and new healing encounters
in Ghana. For a long time, the practice of allopathy in
Ghana is often framed to compete with alternative practices
such as traditional/indigenous and faith-based healing [22].
It is common practice for community members to bypass
allopathic public health facilities and access care from these
alternative providers or healers. Aside from inaccessibility
challenges associated with allopathic healthcare, motiva-
tions for uptake of indigenous health remedies, include
trust (of indigenous healers), proximity, ease of use, previ-
ous relationships, cost-value (sometimes) and poor percep-
tions of the level of competence of the low-cadre allopathic
health workforce [48, 49]. Awah and Phillimore [50] ex-
plore and cast important light on the tension between
clinic-based demands for patients’ ‘compliance’ with treat-
ment guidelines, including repeated strictures against
resorting to ‘traditional’ medicine, and patients’ own will-
ingness to alternate between biomedical and indigenous
practitioners.
Critics of indigenous medicine point out its implica-
tions for service uptake and adherence to allopathic care.
In our study, potential barriers to uptake and adherence
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to antihypertensives relate to the belief that traditional
medicines could cure patients' hypertension. Our explor-
ation, which involved a wider group (patients, service
providers, and policymakers), concurs with the findings
of de-Graft-Aikins [22], where the patients she engaged
set out to seek a cure for their diabetes. Similar claims
are rife in studies of other NCDs and in further African
settings [47]. We note that, until all care providers in
this pluralistic healthcare system are made to understand
that there is as yet no cure, this phenomenon of seeking
cures for ‘incurable’ health conditions will continue.
Therefore, programmes such as ComHIP may learn
from these explorations of local approaches to care-
seeking and medication by understanding patients’ prior-
ities, motivations and preferences when designing inter-
ventions – seeing traditional solutions as
complementary to, rather than competing against, allo-
pathic medications. The popularity of traditional remed-
ies among ComHIP clients is in line with data from
previously reported local studies [51, 52], where pa-
tients sought care from multiple outlets. For example,
the Ghana Herbal Pharmacopoeia reveals that more than
70% of Ghanaians who receive allopathic care, also resort
to alternative health care practices to address their health
needs [53]. Another local study linked such practices to
Ghana’s religious landscape and political history [52]. A
relatively recent Ghanaian study reported prevalent use of
non-prescription medications by persons living with HIV,
a practice mostly self-initiated or implemented with the
acquiescence of some healthcare providers [51]. This
phenomenon has been documented in other African set-
tings [54–57].
Like limited health workforce, limited funding, mis-
prioritization, and restrictive prescribing policies, the
phenomenon of medical pluralism is an important con-
textual challenge to the prevetion/treatment of hyperten-
sion and other NCDs in Ghana. The Ghana Food and
Drug Authority, the Ghana Standards Authority, and
other regulatory bodies need to institute robust monitor-
ing and validation schemes that endorse or reject various
healing options on the formal and informal health deliv-
ery platforms. Furthermore, efforts at improving the
health literacy of the Ghanaian populace may help pro-
vide clarification on the effectiveness or otherwise of
these healing options.
Study strengths and limitations
ComHIP is one of the few comprehensive studies which
deploy a multilevel combination prevention-treatment-
control intervention that engages (patients, community,
and healthcare personnel), educates (patients and
family), and uses supportive tools to increase hyper-
tension literacy, service access, service uptake, and
linkages to care.
This qualitative study involved all the actors and com-
ponents of ComHIP. In doing so, it has been possible to
identify enablers and bottlenecks to implementation and
future scale up. The findings, however, need to be read
along with the following limitations. First, the data pre-
sented in this paper derives from purposively sampled
ComHIP stakeholders and thus precludes generalizability.
It ought to be noted however, that, typical of qualitative
inquiries, the study was not intended produce evidence
generalizable to other settings. Second, although the quali-
tative research assistants were trained to handle courtesy
bias or socially desirable responses on the part of all re-
spondents, we are not able to wholly rule them out. Des-
pite these limitations, this paper sheds light on important
challenges to hypertension and other NCD prevention,
treatment, and control in Ghana. These have the potential
to inform research uptake, as well as provide guidance to
similarly-designed interventions.
Conclusions
Taken together, this paper reveals two layers of chal-
lenges associated with hypertension and related NCDs
prevention and treatment in Ghana. These are the
healthcare system-level challenges relating to governance
and prioritization of NCDs within the Ghana Health
Service care delivery system; human resource con-
straints, task-sharing bottlenecks; and patient-level chal-
lenges relating to non-adherence to medications and
medication side effects. Our data show that the task-
sharing component of ComHIP is acceptable to patients
and healthcare providers, but not to policymakers, and
this has implications on the implementation of ComHIP
and the design of related task-shifting strategies in
Ghana. Although there is no shortage of evidence on the
clear need for such task-sharing strategies in LMICs,
these challenges preclude their implementation. We rec-
ommend meaningful engagement of policy-level gate-
keepers, medical and other relevant professional
associations to buy into the concept of task-sharing.
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